Tioget-F Inhalation Capsules provide an established, clinically unified dry powder inhalation (DPI) combination therapy carefully developed for the continuous maintenance management and long-term stabilization of Chronic Obstructive Pulmonary Disease (COPD) and chronic airway restriction pathways. In professional respiratory care, persistent parasympathetic constriction paired with muscular tightening significantly narrows the bronchial branches, leading to air trapping and progressive lung fatigue. This advanced formulation integrates two independent, highly complementary bronchodilating mechanisms within a single inhalation capsule, delivering target-specific relief directly to the pulmonary tissues without causing broader systemic tracking adjustments.
The formulation operates dynamically across two distinct therapeutic fronts:
-
Tiotropium Bromide: A long-acting muscarinic antagonist (LAMA). It works locally by binding tightly to $M_3$ muscarinic receptors on bronchial smooth muscle cells. By blocking the parasympathetic constricting effects of acetylcholine, it prevents muscle tightening and delivers smooth, steady bronchodilation that persists effectively for a full 24-hour cycle.
-
Formoterol Fumarate Dihydrate: A rapid-onset, long-acting beta-2 adrenergic agonist (LABA). It functions by selectively stimulating $\beta_2$-receptors throughout the lungs, activating adenylate cyclase loops to increase intracellular cyclic AMP. This molecular shift leads to instant smooth muscle relaxation within 1 to 3 minutes of inhalation, maintaining a wide, relaxed airway structure for up to 12 hours.
Key Benefits
-
Advanced Dual Bronchodilation: Unites an anti-cholinergic shield (LAMA) with an advanced beta-agonist (LABA) to target airway constriction from two separate cellular tracks.
-
Rapid & Extended Airways Calm: Formoterol relaxes bronchial spasms within minutes of delivery, while Tiotropium provides stable, round-the-clock maintenance support.
-
Improves Daily Lung Capacity: Drastically drops functional residual lung capacity and air trapping issues, making breathing lighter and supporting increased physical movement.
-
Reduces Exacerbation Risks: Consistent daily maintenance tracking helps establish stable respiratory baselines, preventing sudden, panic-inducing chest flare-ups.
-
Precise Dosing Architecture: Every single inhalation capsule provides a perfectly calibrated dual-active track, backed by Healthgate’s strict pharmaceutical guidelines.
Directions for Use
-
Use exactly as directed by your pulmonologist or respiratory specialist.
-
Tioget-F Capsules are strictly for oral inhalation use only via an inhalation device (like a Rotahaler, Revolizer, or DP-Haler). Do not swallow these capsules orally.
-
Inhalation Step-by-Step: Open your inhalation device chamber. Remove a Tioget-F capsule from its protective blister layout and place it firmly into the chamber base. Close the device tightly until it clicks, then press the piercing button to split open the shell structure. Breathe out completely away from the device to empty your lungs. Place the mouthpiece securely between your teeth and seal your lips around it. Breathe in through your mouth as deeply and rapidly as possible. You should hear the capsule spinning or rattling inside the chamber, indicating the dry powder is releasing correctly. Hold your breath for 5 to 10 seconds, then breathe out gently.
-
Open the device to check if any powder remains; if so, take another deep breath through the mouthpiece. Discard the empty gelatin shell configuration.
-
Important Hygiene Rule: Always rinse your mouth thoroughly with plain water and spit it out after completing your inhalation routine to prevent localized throat dryness or minor irritation tracking errors.
Safety & Precautions
-
Do not alter your daily dosage or stop usage suddenly without professional tracking, as severe bronchospasms or severe breathlessness loops can return sharply.
-
Not for Acute Rescue Use: This product is a slow-acting maintenance medication. Do not use Tioget-F to treat a sudden, acute attack of breathlessness. Always ensure a dedicated short-acting rescue bronchodilator inhaler is accessible for acute emergencies.
-
Inform your specialist before initialization if you have an underlying personal history of closed-angle glaucoma, urinary retention patterns, an enlarged prostate, severe heart conditions (like arrhythmias), or high blood pressure parameters.
-
If you experience immediate worsening of breathing difficulties or unexpected chest tightness right after inhaling a dose (paradoxical bronchospasm), discontinue use instantly and use your rescue inhaler.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 25°C. Do not freeze.
-
Protect from direct sunlight, excessive heat sources, and environmental room moisture pools.
-
Leave the capsules safely inside their original protective packaging configuration until the exact moment of use, as dry powder matrices are highly sensitive to ambient room humidity tracking.
